- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, October 7, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by Becker's Payer Issues covered a study published in the October 2022 issue of The American Journal of Managed Care® (AJMC®). In the study, “Turnover Among New Medicare Advantage Enrollees May Be Greater Than Perceived,” findings revealed that enrollees who join Medicare Advantage undergo significant turnover in the years following enrollment.
Another study published in the AJMC® October issue, “The Impact of HDHPs on Service Use and Spending for Substance Use Disorders,” was referenced by MedCity News. The study showed that offering a high-deductible health plan (HDHP) led to a 6.6% reduction in the probability of using substance use disorder services and a shift in spending from the plan to the enrollee.
A piece by Health Digest cited an article published on AJMC.com, the website of AJMC®. The article, “Chemotherapy Demand Will Rise Significantly by 2040, and Workforce Will Need to Expand With It,” indicated that the number of patients requiring first-line chemotherapy is expected to increase by more than 50% from 2018 to 2040.
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
Accountable Care Organizations and HPV Vaccine Uptake: A Multilevel Analysis
October 24th 2024The authors evaluated whether adolescents receiving care at accountable care organizations (ACOs) vs non-ACOs were more likely to initiate and complete the human papillomavirus (HPV) vaccination series.
Read More
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
